First Four Patients In Bionic Sight’s Optogenetic Gene Therapy Trial Are Able To Detect Light And Motion
March 30, 2021 07:00 ET
|
Bionic Sight
Company shares preliminary results from Phase 1/2 clinical trial with patients who have complete or near-complete blindness NEW YORK, March 30, 2021 (GLOBE NEWSWIRE) -- Bionic Sight, LLC...
Bionic Sight, LLC Doses First Patient in a Phase 1/2 Clinical Trial of a New Investigational Treatment for Blindness caused by Retinitis Pigmentosa
June 16, 2020 07:00 ET
|
Bionic Sight
NEW YORK, June 16, 2020 (GLOBE NEWSWIRE) -- Bionic Sight, LLC announced today that it has dosed the first patient in the Company’s Phase 1/2 clinical trial of BS01, an optogenetic gene therapy for...